Request for feedback on PHARMAC’s initial medical device activity
PHARMAC is seeking feedback on its initial medical device activity. Closed: Friday, 14 June 2013.
PHARMAC is in the process of expanding its role to include procurement and management of medical devices. As part of this work, PHARMAC intends to pick up some specific procurement activities to help develop its systems and generate benefits for the DHBs over the next 12-18 months. We would now like to seek your views on the areas we propose to undertake activity in, and invite comment on key issues to consider in those areas.
We are aware that feedback requests have been made in the past for various reasons, and you may have provided information you think relevant to this request previously either to PHARMAC, or to another agency such as HBL. In this case you only need to refer to your past feedback, and we will locate it.
The document below sets out some background, and while there may be numerous approaches we might consider, we need to determine what will be appropriate in each context. By obtaining your feedback we anticipate it will assist us in building our processes going forward.
We have also attached an outline of the areas we are proposing to undertake activity in and some specific questions about each. We appreciate your time is valuable and hope the detail in this document provides you with an adequate overview of PHARMAC’s current thinking. We do not expect every respondent to answer all the questions, just those that are relevant or of interest to you.
Once we have received feedback from stakeholders, the submissions will be collated and considered. We will use this information to inform which areas to focus on, and help inform the activity in each of these areas. We expect there will be a need for ongoing discussion with stakeholders over the following months as we develop our specific approaches in different areas.
There will be further opportunity to input into this work and we look forward to hearing from you and working with your organisation to help achieve national consistency in managing medical devices, improve transparency of decision-making and improve the cost-effectiveness of public spending to generate savings for re-investment into the health sector.